Compare Regeneron Pharmaceuticals Inc (REGN) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Clear Secure Inc — how do they compare? Regeneron Pharmaceuticals Inc trades at $741.17 (market cap $76.14B), while Clear Secure Inc trades at $43.44 (market cap $4.44B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 17.1× Clear Secure Inc's market cap, and Clear Secure Inc pays the higher dividend (1.33%). Which is the better fit depends on your goals — on Pluang, investors hold Regeneron Pharmaceuticals Inc for 107 Days and Clear Secure Inc for 19 Days on average.
| REGN | YOU | |
|---|---|---|
Market Cap | $76.14B | $4.44B |
Volume | 500,239 | 1,477,828 |
Sector | Health | Technology |
52-Week High | $852.03 | $62.36 |
52-Week Low | $557.73 | $29.61 |
Typical Hold Time | 107 Days | 19 Days |
Enterprise Value | $70.85B | $3.59B |
Dividend Yield | 0.51% | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $747.21, up 0.69% with strong recent earnings beats. The stock shows bearish technical signals but maintains robust fundamentals with 84.86% gross margins and consistent revenue growth. Recent news highlights a major $8 billion immunology alliance expansion with Sanofi, providing significant upfront and milestone payments. Analyst consensus remains strongly bullish with 69% buy ratings and an $849.84 price target, representing 13.7% upside potential from current levels.
REGN presents a compelling growth story with strong profitability and strategic partnerships, though technical indicators suggest near-term consolidation. The expanded Sanofi collaboration and promising clinical trial data provide catalysts, while competition in key therapeutic areas and reliance on blockbuster drugs represent ongoing risks. Wall Street optimism remains high given the company's execution track record and pipeline potential.
Clear Secure (YOU) trades at $43.55, up 2.28% today, with a bullish technical signal despite overbought RSI readings. The company reported strong Q2 2026 earnings, beating estimates with $0.49 EPS, and shows robust revenue growth and profitability, including a 66.66% gross margin. Recent news highlights strategic partnerships, such as with CrowdStrike, and positive analyst coverage.
The outlook is positive, driven by accelerating membership growth and expanding margins, but risks include high valuation multiples and potential market volatility. Analysts have a consensus price target of $61.40, suggesting upside, with 44% buy ratings indicating cautious optimism amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
